Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)
India
· Delayed Price · Currency is INR 367.90
+13.40 (3.78%)
Jun 6, 2025, 3:29 PM IST
Dr. Agarwal's Health Care Revenue
In the fiscal year ending March 31, 2025, Dr. Agarwal's Health Care had annual revenue of 17.11B INR with 28.44% growth. Dr. Agarwal's Health Care had revenue of 4.60B in the quarter ending March 31, 2025, with 31.92% growth.
Revenue
17.11B
Revenue Growth
+28.44%
P/S Ratio
6.80
Revenue / Employee
n/a
Employees
4,214
Market Cap
116.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 17.11B | 3.79B | 28.44% |
| Mar 31, 2024 | 13.32B | 3.14B | 30.86% |
| Mar 31, 2023 | 10.18B | 3.22B | 46.25% |
| Mar 31, 2022 | 6.96B | 2.25B | 47.73% |
| Mar 31, 2021 | 4.71B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |